Inflammatory Bowel Disease in Children

Authors

  • Nabila Annisa Harum Faculty of Medicine Universitas Airlangga – Dr. Soetomo General Hospital, Surabaya, Indonesia
  • Primadita Syahbani Faculty of Medicine Universitas Airlangga – Dr. Soetomo General Hospital, Surabaya, Indonesia
  • Idznika Nurannisa Wibowo Faculty of Medicine Universitas Airlangga – Dr. Soetomo General Hospital, Surabaya, Indonesia

DOI:

https://doi.org/10.58427/apghn.3.3.2024.38-51

Keywords:

children , crohn's disease, inflammatory bowel disease, ulcerative colitis

Abstract

Background: Pediatric inflammatory bowel disease (IBD) is an idiopathic inflammatory disease in the digestive system with chronic onset, which often presents with unique and atypical phenotypes. This study aimed to dissect the important features of inflammatory bowel disease in children

Discussion: The two types of inflammatory bowel disease (IBD) are ulcerative colitis (UC) and Crohn’s disease (CD). In children, IBD may exhibit classic symptoms such as weight loss, abdominal pain, and bloody diarrhea. However, many patient present with atypical symptoms such as isolated poor growth, anemia, or other extraintestinal manifestations. Early diagnosis of IBD in children is crucial as delayed diagnosis may lead to serious complications like bowel narrowing or abnormal connections, and stunted growth. The recommended initial evaluations in a pediatric patient with suspected IBD are complete blood test, stool examination, endoscopy and imaging. Furthermore, the aims of IBD treatment in children are to improve quality of life, relieve symptoms, promote normal growth, and prevent complications, all while minimizing medication side effects.

Conclusion: Early diagnosis and treatment are essential in managing pediatric IBD. Additionally, addressing the disease's impact on bone health, growth, development, and psychosocial well-being is also crucial to achieve comprehensive management.

References

Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr. 2015;169(11):1053-1060. https://doi.org/10.1001/jamapediatrics.2015.1982 DOI: https://doi.org/10.1001/jamapediatrics.2015.1982

Maccioni F, Viola F, Carrozzo F, Di Nardo G, Pino AR, Staltari I, et al. Differences in the location and activity of intestinal Crohn’s disease lesions between adult and paediatric patients detected with MRI. Eur Radiol. 2012; 22(11):2465–2477 DOI: https://doi.org/10.1007/s00330-012-2482-6

Bouhuys M, Lexmond WS, van Rheenen PF. Pediatric Inflammatory Bowel Disease. Pediatrics. 2023 Jan 1;151(1):e2022058037. https://doi.org/10.1542/peds.2022-058037 DOI: https://doi.org/10.1542/peds.2022-058037

Ledder O, Sonnino M, Birimberg-Schwartz L, Escher JC, Russell RK, Orlanski-Meyer E.et al. Appraisal of the PIBD-classes criteria: a multicentre validation. J Crohn’s Colitis. 2020;14(12):1672–1679. https://doi.org/10.1093/ecco-jcc/jjaa103

Ricciuto A, Mack DR, Huynh HQ, Jacobson K, Otley AR, deBruyn J, et al. Diagnostic delay is associated with complicated disease and growth impairment in paediatric Crohn’s Disease. J Crohn’s Colitis. 2021;15(3):419–431. https://doi.org/10.1093/ecco-jcc/jjaa197 DOI: https://doi.org/10.1093/ecco-jcc/jjaa197

Long D, Wang C, Huang Y, Mao C, Xu Y, Zhu Y. Changing epidemiology of inflammatory bowel disease in children and adolescents. Int J Colorectal Dis. 2024;39(1):73. Published 2024 May 18. https://doi.org/10.1007/s00384-024-04640-9 DOI: https://doi.org/10.1007/s00384-024-04640-9

Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease. World J Gastroenterol. 2006;12(20):3204-3212. https://doi.org/10.3748/wjg.v12.i20.3204 DOI: https://doi.org/10.3748/wjg.v12.i20.3204

Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw. 2017;17(1):25 . https://doi.org/10.4110/in.2017.17.1.25

Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. 2018;53(4):379-389. https://doi.org/10.1080/00365521.2018.1447597 DOI: https://doi.org/10.1080/00365521.2018.1447597

Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26. https://doi.org/10.5217/ir.2018.16.1.26 DOI: https://doi.org/10.5217/ir.2018.16.1.26

Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res. 2019;2019:1-16. https://doi.org/10.1155/2019/7247238 DOI: https://doi.org/10.1155/2019/7247238

Jarmakiewicz-Czaja S, Zielińska M, Sokal A, Filip R. Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update. Genes. 2022;13(12):2388. https://doi.org/10.3390/genes13122388 DOI: https://doi.org/10.3390/genes13122388

Hadad JE, Schreiner P, Vavricka SR, Greuter T. The Genetics of Inflammatory Bowel Disease. Mol Diagn Ther. 2023;28(1):27-35. https://doi.org/10.1007/s40291-023-00678-7 DOI: https://doi.org/10.1007/s40291-023-00678-7

Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, De Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.Int J Mol Sci. 2022;23(7):3464. https://doi.org/10.3390/ijms23073464 DOI: https://doi.org/10.3390/ijms23073464

Shan Y, Lee M, Chang EB. The Gut Microbiome and Inflammatory Bowel Diseases. Annu Rev Med. 2022;73(1):455-468.https://doi.org/10.1146/annurev-med-042320-021020 DOI: https://doi.org/10.1146/annurev-med-042320-021020

Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M, Miyamoto J. Inflammatory Bowel Diseases and Gut Microbiota. Int J Mol Sci. 2023;24(4):3817. https://doi.org/10.3390/ijms24043817 DOI: https://doi.org/10.3390/ijms24043817

Singh N, Bernstein CN. Environmental risk factors for inflammatory bowel disease. nited European Gastroenterol J. 2022;10(10):1047-1053. https://doi.org/10.1002/ueg2.12319 DOI: https://doi.org/10.1002/ueg2.12319

Hasosah M, Alhashmi W, Abualsaud R, Alamoudi A, Aljawad A, Tunkar M, et al. Environmental Risk Factors for Childhood Inflammatory Bowel Diseases: A Multicenter Case-Control Study. Children (Basel). 2022;9(3):438. https://doi.org/10.3390/children9030438 DOI: https://doi.org/10.3390/children9030438

Duan R, Zhang C, Li G, Li J, Duan L. Antibiotic exposure and risk of new-onset inflammatory bowel disease: a systematic review and dose-response meta-analysis. Clin Gastroenterol Hepatol. 2024; S1542-3565(24)00218-0. https://doi.org/10.1016/j.cgh.2024.02.010 DOI: https://doi.org/10.1016/j.cgh.2024.02.010

Örtqvist AK, Lundholm C, Halfvarson J, Ludvigsson JF, Almqvist C. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut. 2019;68(2):218-225. https://doi.org/10.1136/gutjnl-2017-314352 DOI: https://doi.org/10.1136/gutjnl-2017-314352

Lee WS, Song ZL, Wong SY, Gan CW, Koay ZL, Em JM, et al. Environmental risk factors for inflammatory bowel disease: A case control study in Southeast Asian children. J Paediatr Child Health. 2022;58(5):782-790. https://doi.org/10.1111/jpc.15830 DOI: https://doi.org/10.1111/jpc.15830

Carreras-Torres R, Ibáñez-Sanz G, Obón-Santacana M, Duell EJ, Moreno V. Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study. Sci Rep. 2020;10(1). https://doi.org/10.1038/s41598-020-76361-2 DOI: https://doi.org/10.1038/s41598-020-76361-2

Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. Int J Mol Sci. 2023;24(2):1526. https://doi.org/10.3390/ijms24021526 DOI: https://doi.org/10.3390/ijms24021526

Lu Q, Yang MF, Liang YJ, Xu J, Xu HM, Nie Y, et al. Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. J Inflamm Res. 2022;15:1825-1844. https://doi.org/10.2147/JIR.S353038 DOI: https://doi.org/10.2147/JIR.S353038

Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019;12(2):113-122. https://doi.org/10.25122/jml-2018-0075. DOI: https://doi.org/10.25122/jml-2018-0075

Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-753. https://doi.org/10.1136/gut.2005.082909. DOI: https://doi.org/10.1136/gut.2005.082909

Ledder O, Sonnino M, Birimberg-Schwartz L, Escher JC, Russell RK, Orlanski-Meyer E,et al. Appraisal of the PIBD-classes criteria: a multicentre validation. J Crohns Colitis. 2020;14(12):1672–1679. https://doi.org/10.1093/ecco-jcc/jjaa103 DOI: https://doi.org/10.1093/ecco-jcc/jjaa103

IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41(1):1-7. https://doi.org/10.1097/01.mpg.0000163736.30261.82 DOI: https://doi.org/10.1097/01.MPG.0000163736.30261.82

Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795-806.https://doi.org/10.1097/MPG.0000000000000239 DOI: https://doi.org/10.1097/MPG.0000000000000239

Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw. 2017;17(1):25-40. https://doi.org/10.4110/in.2017.17.1.25 DOI: https://doi.org/10.4110/in.2017.17.1.25

Moon JS. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019;22(1):50-56. https://doi.org/10.5223/pghn.2019.22.1.50 DOI: https://doi.org/10.5223/pghn.2019.22.1.50

Rahmani P, Rasti G, Gorgi M, Motamed F, Sharifi P. Extraintestinal manifestation of inflammatory bowel disease and associated factors in pediatric patients. Ann Med Surg (Lond). 2022;75:103363. https://doi.org/10.1016/j.amsu.2022.103363 DOI: https://doi.org/10.1016/j.amsu.2022.103363

Pivac I, Jelicic Kadic A, Despot R, Zitko V, Tudor D, Runjic E, et al. Characteristics of the Inflammatory Bowel Disease in Children: A Croatian Single-Centre Retrospective Study. Children (Basel). 2023;10(10):1677. https://doi.org/10.3390/children10101677 DOI: https://doi.org/10.3390/children10101677

Kapoor A, Bhatia V, Sibal A. Pediatric Inflammatory Bowel Disease. Indian Pediatr. 2016;53(11):993-1002. https://doi.org/10.1007/s13312-016-0975-0. DOI: https://doi.org/10.1007/s13312-016-0975-0

Henderson P, Anderson NH, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(5):637–645. https://doi.org/10.1038/ajg.2013.131 DOI: https://doi.org/10.1038/ajg.2013.131

Spiceland CM, Lodhia N. Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment. World J Gastroenterol. 2018;24(35):4014-4020. https://doi.org/10.3748/wjg.v24.i35.4014 DOI: https://doi.org/10.3748/wjg.v24.i35.4014

Magro F, Langner C, Driessen A, Ensari K, Geboes GJ, Mantzaris V, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohn’s Colitis. 2013;7(10):827-851. https://doi.org/10.1016/j.crohns.2013.06.001 DOI: https://doi.org/10.1016/j.crohns.2013.06.001

Kilcoyne A, Kaplan JL, Gee MS. Inflammatory bowel disease imaging: Current practice and future directions. World J Gastroenterol. 2016;22(3):917-932. https://doi.org/10.3748/wjg.v22.i3.917 DOI: https://doi.org/10.3748/wjg.v22.i3.917

Athanasakos A, Mazioti A, Economopoulos N, Kontopoulou C, Stathis G, Filippiadis D, et al. Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel. Insights Imaging. 2015;6(1):73-83. https://doi.org/10.1007/s13244-014-0377-6 DOI: https://doi.org/10.1007/s13244-014-0377-6

Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. https://doi.org/10.1053/j.gastro.2020.12.031 DOI: https://doi.org/10.1053/j.gastro.2020.12.031

Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr. 2012;55(3):340-361. https://doi.org/10.1097/MPG.0b013e3182662233 DOI: https://doi.org/10.1097/MPG.0b013e3182662233

Guariso G, Gasparetto M. Treating children with inflammatory bowel disease: Current and new perspectives. World J Gastroenterol. 2017;23(30):5469-5485. https://doi.org/10.3748/wjg.v23.i30.5469 DOI: https://doi.org/10.3748/wjg.v23.i30.5469

Oliveira SB, Monteiro IM. Diagnosis and management of inflammatory bowel disease in children. BMJ. 2017;357:j2083. https://doi.org/10.1136/bmj.j2083 DOI: https://doi.org/10.1136/bmj.j2083

van Rheenen PF, Aloi M, Assa A, Bronsky J, Escher JC, Fagerberg UL, et al. The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020. https://doi.org/10.1093/ecco-jcc/jjaa161 DOI: https://doi.org/10.1093/ecco-jcc/jjaa161

Shapiro JM, Subedi S, LeLeiko NS. Inflammatory Bowel Disease [published correction appears in Pediatr Rev. 2016 Sep;37(9):405. doi: 10.1542/pir.379405]. Pediatr Rev. 2016;37(8):337-347. https://doi.org/10.1542/pir.2015-0110. DOI: https://doi.org/10.1542/pir.2015-0110

Wyllie R, Hyams JS. Pediatric Gastrointestinal Disease. Pathophysiology, diagnosis, management. Philadelphia: WB Saunders Co. 1993: 742-787

Published

2024-08-31

How to Cite

1.
Inflammatory Bowel Disease in Children. Arch Pediatr Gastr Hepatol Nutr [Internet]. 2024 Aug. 31 [cited 2024 Nov. 21];3(3):38-51. Available from: https://apghn.com/index.php/journal/article/view/69